Abstract:Background: Women who are heterozygous for variants in the ataxia telangiectasia mutated (ATM) gene, ATM carriers, have been reported to be at increased risk for breast cancer compared with women who do not posses an alteration in this gene. Aside from BRCA1 and BRCA2, there are few data on breast cancer susceptibility genes in African-American women. The goal of this study was to determine whether there is evidence that ATM is a breast cancer susceptibility gene in African-American women. Methods: One hundred thirty two African-American women were screened for ATM sequence alterations. Thirty-seven (28%) were women with a histological diagnosis of breast cancer (cases). These women were not selected on the basis of a breast cancer family history. Ninety-five (72%) were age-matched women who had not been diagnosed with breast cancer (controls). Genetic variants were identified using denaturing high performance liquid chromatography (DHPLC). Results: Twenty-three of the 37 (62%) cases possessed at least one ATM variant. Fifty-eight of the 95 (61%) (P = 0.54) age-matched controls harbored at least one ATM variant. For subjects specifically possessing missense variants, 46% of cases and 48% of controls had these types of sequence variants. In addition, 19% of cases and 34% of controls possessed multiple ATM sequence variants (P = 0.07). The most common polymorphisms were the 378 T --> A which was seen in 19% of cases and 27% of controls (P = 0.22), 5557 G --> A identified in 22% of cases and 18% of controls (p = 0.40), 2685 A --> G which was detected in 11% of cases and 6% of controls (P = 0.22), and 1254 A --> G which was found in 3% of cases and 9% of controls (P = 0.36). Hence, there were no significant differences in any of the genetic variants detected between the case and control subjects. Conclusion: We found no statistically significant differences in the overall frequency of ATM variants, nor any specific variant type or group, between African-American women who had been diagnosed with breast cancer compared with an age-matched cohort of African-American women who did not have breast cancer. ATM, therefore, does not appear to represent a breast cancer susceptibility gene in the general African-American population.

Lack of Association Between Atm C.1066-6t > G Mutation and Breast Cancer Risk: A Meta-Analysis of 8,831 Cases and 4,957 Controls

The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis

The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis

Discovery of a Pathogenic Variant Rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations

Two-stage case-control study of common ATM gene variants in relation to breast cancer risk

Association Between ATM Rs1801516 Polymorphism and Cancer Susceptibility: a Meta-Analysis Involving 12,879 Cases and 18,054 Controls

Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk

Association of ATM and BMI‐1 Genetic Variation with Breast Cancer Risk in Han Chinese

The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis

Prevalence and Characterization of ATM Germline Mutations in Chinese BRCA1/2-negative Breast Cancer Patients

Screening for ATM sequence alterations in African-American women diagnosed with breast cancer

Abstract P3-12-04: RAD51 135G>C Does Not Modify Breast Cancer Risk in Non-BRCA1/2 Mutation Carriers: Evidence from a Meta-Analysis of 12 Studies

Gene-environment Interaction for Polymorphisms in Ataxia Telangiectasia-Mutated Gene and Radiation Exposure in Carcinogenesis: Results from Two Literature-Based Meta-Analyses of 27120 Participants

Penetrance of ATM Gene Mutations in Breast Cancer: A Meta‐Analysis of Different Measures of Risk

Lack of Association Between Catechol-O-methyltransferase Val108/158Met Polymorphism and Breast Cancer Risk: a Meta-Analysis of 25,627 Cases and 34,222 Controls

Cancer risk according to type and location of ATM mutation in ataxia‐telangiectasia families

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects

Single Nucleotide Polymorphism in ATM and Non-Small Cell Lung Cancer Susceptibility

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects

Association Between BRCA1 Rs799917 Polymorphism and Breast Cancer Risk: A Meta-Analysis of 19,878 Subjects